ModiLite Clinical Trials

Multicentric Randomized Controlled Study of Percutaneous Laser Ablation Versus Follow Up in Benign Thyroid Nodules. Long Term Results

Multicentre Randomized Clinical Trial
No. of patients enrolled: 200
Reference Study Centres: 4, Azienda Ospedaliero-Universitaria di Pisa – Presidio di Cisanello, Ospedale Regina Apostolorum, Azienda Ospedaliera di Perugia, Arcispedale Santa Maria Nuova
Study status: Completed
Registered on ClinicalTrial.gov: https://clinicaltrials.gov/ct2/show/NCT00858104
Publications of the results: Long-term Efficacy of Ultrasound-Guided Laser Ablation for Benign Solid Thyroid Nodules. Results of a Three-Year Multicenter Prospective Randomized Trial, Papini E, Rago T, Gambelunghe G, Valcavi R, Bizzarri G, Vitti P, De Feo P, Riganti F, Misischi I, Di Stasio E, Pacella CM. J Clin Endocrinol Metab. 2014 Oct

Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules (LARA)

Randomised Clinical Trial
No. of patients enrolled: 60
Reference Study Centre: Ospedale, Santa Maria Goretti, Latina
Study status: enrolment of patient
Registered on ClinicalTrial.gov: https://clinicaltrials.gov/ct2/show/NCT02714946?term=laser+versus+radiofrequency+thyroid&rank=1

 

Pilot Study to Evaluate the Safety and Efficacy of Percutaneous Laser Ablation of Thyroid Papillary Microcarcinoma

Randomised Clinical Trial
No. of patients enrolled: 10
Reference Study Centre: Memorial Sloan Kettering ,New York
Study status: patients enrolment
Registered on ClinicalTrial.gov: https://www.clinicaltrials.gov/ct2/show/NCT04623801

AgathaLite Clinical Trials

No Clinical Trials at this current time

SoracteLite Clinical Trials

Transperineal Laser Ablation for Treatment of LUTS Due to Benign Prostatic Obstruction

No. of Patients: 20
Sponsor: Academisch Medisch Centrum – Universiteit van Amsterdam (AMC-UvA)
State of the Study: patients recruitment
Registered on ClinicalTrial.gov: https://clinicaltrials.gov/ct2/show/NCT03653117

Registry of Transperineal Laser Ablation for Treatment of Lower Urinary Tract Symptoms With Use of the Echolaser® Device: A Multicentre, International Registry to Evaluate the Treatment of Lower Urinary Tract Symptoms in Terms of Long-term Efficacy, Functional Outcomes and Safety

No. of Patients: 500
Sponsor: Academisch Medisch Centrum – Universiteit van Amsterdam (AMC-UvA)
State of the Study: patients recruitment
Registered on ClinicalTrial.gov: ClinicalTrial.gov: https://clinicaltrials.gov/ct2/show/NCT03776006

Tolerability of percutaneous ablation Neodymium Laser in patients suffering from Benign Prostatic Hyperplasia (BPH): Prospective Observational Pilot Study

No. of patients enrolled: 10
Reference centre of the study: Pesenti Fenaroli Hospital, Alzano Lombardo (BG)
Promoter: Dr. Gianluigi Patelli
Study Status: Completed.

 

Tolerability of percutaneous ablation Neodymium Laser in patients suffering from Benign Prostatic Hyperplasia (BPH): Prospective Observational Pilot Study

No. of Patient: 10

Reference centre of the study: Ospedale Pesenti Fenaroli, Alzano Lombardo (BG)

Sponsor: Dr. Gianluigi Patelli

State of the Study: Completed

 

Transperineal Laser Ablation for Benign Prostatic Hyperplasia with Bladder Outlet Obstruction

No. of Patient: 20

Reference centre of the study: Urology Specialist Group, Miami Florida

State of the Study: Completed

Registered on ClinicalTrial.gov: https://www.clinicaltrials.gov/ct2/show/NCT04760483

 

Transperineal Laser Ablation for Treatment of LUTS Due to Benign Prostatic Obstruction

No. of Patient: 140

Reference centre of the study: Shanghai Sixth People’s Hospital, China

State of the Study: patients recruitment

Link of registration of the Clinical Trial: http://www.chictr.org.cn/showproj.aspx?proj=34314

 

Trans-perineal laser ablation of prostate adenoma for the micro-invasive treatment of obstructive symptoms from benign prostatic hypertrophy: Randomized clinical study of comparison with transurethral prostate resection (TURP)

No. of Patient: 50

Reference centre of the study: Ospedale San Carlo di Nancy, Roma

State of the Study: patients recruitment

Link of registration of the Clinical Trial: https://www.clinicaltrials.gov/ct2/show/NCT04781049

 

Short-term efficacy of transperineal laser ablation with image fusion in prostate cancer patients: Multidisciplinary interventional pilot study

No. of Patient: 30

Reference centre of the study: Ospedale Tor Vergata, Roma

State of the Study: Completed

Link of registration of the Clinical Trial: https://www.clinicaltrials.gov/ct2/show/NCT04045756

 

Transperineal laser ablation for focal treatment of prostate cancer: the safety and ablative efficacy of transperineal laser ablation for focal prostate cancer treatment compared with radical prostatectomy histological analysis

No. of Patient: 12

Reference centre of the study and Sponsor: Academisch Medisch Centrum – Universiteit van Amsterdam (AMC-UvA)

State of the Study: Completed

Registered on ClinicalTrial.gov: https://www.clinicaltrials.gov/ct2/show/NCT04170478

 

Transperineal Laser Ablation Treatment for Prostate Cancer Registry: a Retrospective and Multicenter Evaluation

No. of Patient: 200

Reference centre of the study and Sponsor: Academisch Medisch Centrum – Universiteit van Amsterdam (AMC-UvA)

State of the Study: patients recruitment

Registered on ClinicalTrial.gov: https://www.clinicaltrials.gov/ct2/show/NCT05163197

PBLite Clinical Trials

Radiofrequency Versus Laser Ablation for Hepatocellular Carcinoma

Randomised Clinical Trial
No. of patients enrolled: 140
Reference Study Centre: Cardarelli Hospital, Naples
Study Status: Completed
Registered on ClinicalTrial.gov: https://clinicaltrials.gov/ct2/show/NCT01096914?term=laser+radiofrequency+liver&rank=1
Publication of the results: Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis:
A randomized trial, Di Costanzo GG1, Tortora R, D’Adamo G, De Luca M, Lampasi F, Addario L, Galeota Lanza A, Picciotto FP, Tartaglione MT, Cordone G, Imparato M, Mattera S, Pacella CM. J Gastroenterol Hepatol. 2015 Mar;30(3):559-65.